NSE: ONESOURCE · Pharmaceuticals & Biotechnology
Is OneSource Specialty Pharma safe?
OneSource Specialty Pharma is rated High Risk on Stockfame's red-flag screen (score 13/100): 1 critical, 2 major and 1 minor flags across 12 checks.
+ Add to watchlist
Data as of 18 Nov 2026 · NSE filings & annual results
13/100
Serious red flag in the filings
1 critical2 major1 minor8 OK
See the full red-flag report for OneSource Specialty Pharma
Create a free account to unlock all 14 checks — promoter pledging & selling, earnings quality, debt, governance and surveillance — with the evidence and links to the exchange filings.
- Every flag explained in plain English
- Evidence with NSE filing links
- Save stocks to your watchlist
Questions about OneSource Specialty Pharma
Is OneSource Specialty Pharma stock safe to invest in?
OneSource Specialty Pharma is rated High Risk on Stockfame's red-flag screen (score 13/100): 1 critical, 2 major and 1 minor flags across 12 checks. This is an educational screen of public filings, not investment advice.
This page is an automated, rule-based screen of public disclosures for educational purposes. It is not a recommendation to buy, sell or hold. Methodology.